Literature DB >> 1385114

The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity.

D Hollenbaugh1, L S Grosmaire, C D Kullas, N J Chalupny, S Braesch-Andersen, R J Noelle, I Stamenkovic, J A Ledbetter, A Aruffo.   

Abstract

Signals delivered to B cells via CD40 can synergize with those provided by other B cell surface receptors to induce B cell proliferation and antibody class switching as well as modulate cytokine production and cell adhesion. Recently, it has been shown that the ligand for CD40 is a cell surface protein of approximately 39 kDa expressed by activated T cells, gp39. Here we report on the isolation and characterization of a cDNA clone encoding human gp39, a type II membrane protein with homology to TNF, and the construction and characterization of a soluble recombinant form of gp39. COS cell transfectants expressing gp39 synergized with either anti-CD20 mAb or PMA to drive strong B cell proliferation and alone were able to drive B cells to proliferate weakly. In all cases the B cell proliferation induced by gp39-expressing COS cells was reduced to background levels by the addition of soluble CD40. Unlike gp39-expressing COS cells, recombinant soluble gp39 was not mitogenic alone and required co-stimulation to drive B cell proliferation. These results suggest that B cells require a second signal besides gp39-CD40 to drive proliferation and that soluble gp39 alone in a non-membrane bound form is able to provide co-stimulatory signals to B cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385114      PMCID: PMC557004          DOI: 10.1002/j.1460-2075.1992.tb05530.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  44 in total

Review 1.  The pathophysiology of tumor necrosis factors.

Authors:  P Vassalli
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

2.  Anti-CD40 monoclonal antibodies or CD4+ T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways.

Authors:  H Gascan; J F Gauchat; G Aversa; P Van Vlasselaer; J E de Vries
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

3.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

4.  CD44 is the principal cell surface receptor for hyaluronate.

Authors:  A Aruffo; I Stamenkovic; M Melnick; C B Underhill; B Seed
Journal:  Cell       Date:  1990-06-29       Impact factor: 41.582

5.  Association between IL-6 and CD40 signaling. IL-6 induces phosphorylation of CD40 receptors.

Authors:  E A Clark; G Shu
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

6.  Long-term human B cell lines dependent on interleukin-4 and antibody to CD40.

Authors:  J Banchereau; P de Paoli; A Vallé; E Garcia; F Rousset
Journal:  Science       Date:  1991-01-04       Impact factor: 47.728

7.  CD40 signaling activates CD11a/CD18 (LFA-1)-mediated adhesion in B cells.

Authors:  T B Barrett; G Shu; E A Clark
Journal:  J Immunol       Date:  1991-03-15       Impact factor: 5.422

8.  Molecular and biological characterization of a murine ligand for CD40.

Authors:  R J Armitage; W C Fanslow; L Strockbine; T A Sato; K N Clifford; B M Macduff; D M Anderson; S D Gimpel; T Davis-Smith; C R Maliszewski
Journal:  Nature       Date:  1992-05-07       Impact factor: 49.962

9.  Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines.

Authors:  A Aruffo; M T Dietsch; H Wan; K E Hellström; I Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

10.  The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins.

Authors:  A Aruffo; M B Melnick; P S Linsley; B Seed
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  107 in total

1.  Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.

Authors:  M Koshy; D Berger; M K Crow
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Early growth response-1 is required for CD154 transcription.

Authors:  Randy Q Cron; Rupa Bandyopadhyay; Anna Genin; Michael Brunner; Gilbert J Kersh; Jiyi Yin; Terri H Finkel; Mary K Crow
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

3.  A functional CD40 receptor is expressed in pancreatic beta cells.

Authors:  D Klein; F Barbé-Tuana; A Pugliese; H Ichii; D Garza; M Gonzalez; R D Molano; C Ricordi; R L Pastori
Journal:  Diabetologia       Date:  2005-02-03       Impact factor: 10.122

4.  Soluble CD40 ligand levels in acute pulmonary embolism: a prospective, randomized, controlled study.

Authors:  Zeynettin Kaya; Kurtulus Ozdemir; Mehmet Kayrak; Enes Elvin Gul; Gokhan Altunbas; Cetin Duman; Aysel Kiyici
Journal:  Heart Vessels       Date:  2011-04-14       Impact factor: 2.037

5.  Immunological and genetic analysis of 65 patients with a clinical suspicion of X linked hyper-IgM.

Authors:  K C Gilmour; D Walshe; S Heath; G Monaghan; S Loughlin; T Lester; G Norbury; C M Cale
Journal:  Mol Pathol       Date:  2003-10

6.  Central nervous system toxoplasmosis with an increased proportion of circulating gamma delta T cells in a patient with hyper-IgM syndrome.

Authors:  L E Leiva; J Junprasert; D Hollenbaugh; R U Sorensen
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

7.  Premature labor: a state of platelet activation?

Authors:  Offer Erez; Roberto Romero; Debra Hoppensteadt; Jawed Fareed; Tinnakorn Chaiworapongsa; Juan Pedro Kusanovic; Shali Mazaki-Tovi; Francesca Gotsch; Nandor Gabor Than; Edi Vaisbuch; Chong Jai Kim; Jimmy Espinoza; Pooja Mittal; Neil Hamill; Chia-Ling Nhan-Chang; Moshe Mazor; Sonia Hassan
Journal:  J Perinat Med       Date:  2008       Impact factor: 1.901

8.  Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.

Authors:  C Ferran; F Dautry; S Mérite; K Sheehan; R Schreiber; G Grau; J F Bach; L Chatenoud
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Trypanosoma cruzi amastigote adhesion to macrophages is facilitated by the mannose receptor.

Authors:  S Kahn; M Wleklinski; A Aruffo; A Farr; D Coder; M Kahn
Journal:  J Exp Med       Date:  1995-11-01       Impact factor: 14.307

Review 10.  Molecular and genetic basis of X-linked immunodeficiency disorders.

Authors:  J M Puck
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.